tiprankstipranks
Quince Therapeutics (QNCX)
NASDAQ:QNCX
US Market
QNCX
Quince Therapeutics
RESEARCH TOOLSreports
Want to see QNCX full AI Analyst Report?

Quince Therapeutics (QNCX) Income Statement

1,052 Followers

Quince Therapeutics Income Statement

Last quarter (Q4 2025), Quince Therapeutics's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q4, Quince Therapeutics's net income was $-39.46M. See Quince Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Mar 24Dec 22Dec 21
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ -142.00K$ 0.00$ 0.00$ 0.00$ 0.00
Operating Expenses
$ 50.29M$ 57.28M$ 34.62M$ 52.02M$ 90.32M
Depreciation and Amortization
$ 142.00K$ 186.00K$ 322.00K$ 204.00K$ 344.00K
EBITDA
$ -50.29M$ -35.98M$ -26.82M$ -50.99M$ -89.97M
Operating Income
$ -50.43M$ -57.28M$ -34.62M$ -52.02M$ -90.32M
Other Income/Expenses
$ -30.34M$ 544.00K$ 3.04M$ 71.00K$ 373.00K
Pretax Income
$ -80.77M$ -56.74M$ -31.58M$ -51.94M$ -89.94M
Net Income
$ -83.98M$ -56.83M$ -31.39M$ -51.66M$ -89.94M
Per Share Metrics
Basic EPS
$ -16.80$ -13.10$ -8.40$ -15.40$ -30.30
Diluted EPS
$ -16.80$ -13.10$ -8.40$ -15.40$ -30.30
Weighted Average Shares Outstanding
 5.01M 4.33M 3.72M 3.35M 2.97M
Weighted Average Shares Outstanding (Diluted)
 5.01M 4.33M 3.72M 3.35M 2.97M
Currency in USD

Quince Therapeutics Earnings and Revenue History